Access our publications on PubMed

 

Patents

1. Pollastri, M.P., Mehta, N., Devine, W., Woodring, J., Swaminathan, U., Mensa-Wilmot, K. “Protozoan parasite growth inhibitors”. US Patent Application No. 14/660,662, 17 March 2015.
2. Pollastri, M.P., Rodriguez, A. “Novel Anti Trypanosoma Cruzi Compounds That Inhibit TcCYP51” US Provisional Application No. 61/755,147, Jan. 22, 2013.
3. Lewis, K., Conlon, B., Nelson, M.L., Pollastri, M.P., Dahl, T.A. “Methods of eradicating bacterial cell populations.” PCT/US12/31882
4. Sherr, D.S., Pollastri, M.P., Schlezinger, J., Haigh Molina, S.E., Schaus, S.E., Giguere, J.R. “Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics.” PCT/US11/45526, U.S. Serial No. 13/812375
5. Pollastri, M.P., Navarro, M., Beverley, S., Rodriguez, A. “Antiparasitic agents based on mTOR inhibitors” PCT/US11/43557
6. Chang, G., Didiuk, M. T. Finneman, J. I., Garigiapati, R. S., Kelley, R. M., Perry, D. A., Ruggeri, R. B., Bechle, B. M., Pollastri, M. P. “Preparation of 1,2,4-substituted-1,2,3,4-tetrahydro-and 1,2-dihydroquinoline and 1,2,3,4-tetrahydroquinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity.” WO 2004085401.
7. Bechle, B.M., Chang, G.C., Diduik, M., Garigipati, R.S., Kelley, R.M., Perry, D.A., Pollastri, M.P. Ruggeri, R.B. “Quinoline and quinoxaline compounds.” US11305874